LDL receptor–mediated endocytosis of Escherichia coli α-hemolysin mediates renal epithelial toxicity
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2505482122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Hunter W Kuhn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110. Hauptthemen laut MEDLINE: Hemolysin Proteins, Endocytosis, Escherichia coli Proteins, Uropathogenic Escherichia coli. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
The α-hemolysin (HlyA) of uropathogenic Escherichia coli (UPEC) is a pore-forming toxin (PFT) that is thought to function by disrupting the host cell plasma membrane. Although CD18 (LFA-1) has been implicated as a receptor on myeloid cells, the mechanisms underlying HlyA cytotoxicity to epithelial cells are poorly defined. Here, we show that HlyA secretion by UPEC markedly intensifies renal tubular epithelial injury in a murine model of ascending pyelonephritis. A CRISPR-Cas9 loss-of-function screen in renal collecting duct cells revealed an unexpected requirement for clathrin-mediated endocytosis in HlyA-induced cytotoxicity. Following internalization, HlyA triggered lysosomal permeabilization, resulting in protease leakage, cytoplasmic acidification, and mitochondrial impairment, culminating in rapid epithelial cell death—a pathway distinct from canonical membrane-disrupting mechanisms of other PFTs. Moreover, we identify the low-density lipoprotein receptor (LDLR) as a critical epithelial receptor for HlyA; genetic ablation or competitive inhibition of the HlyA–LDLR interaction fully abrogated cytotoxicity. Our findings detail a paradigm for HlyA function in which epithelial toxicity relies on LDLR-mediated endocytic uptake rather than plasma membrane poration. These mechanistic insights illuminate potential therapeutic strategies to attenuate HlyA-mediated tissue damage during UPEC infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
ORCID-Profile: Hunter W Kuhn, Madeleine R Smither, Michael S Diamond, David A Hunstad
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIGMS NIH HHS
Zitieren
APA
Kuhn, H. W., Smither, M. R., Jin, R. J., Collins, C. A., Ma, H., Sina, J., Gaut, J. P., Diamond, M. S., & Hunstad, D. A. (2025). LDL receptor–mediated endocytosis of Escherichia coli α-hemolysin mediates renal epithelial toxicity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2505482122
Vancouver
Kuhn HW, Smither MR, Jin RJ, Collins CA, Ma H, Sina J, et al. LDL receptor–mediated endocytosis of Escherichia coli α-hemolysin mediates renal epithelial toxicity. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2505482122
BibTeX
@article{Kuhn2025,
author = {Kuhn, Hunter W and Smither, Madeleine R and Jin, Rachel J and Collins, Christina A and Ma, Hongming and Sina, Jason and Gaut, Joseph P and Diamond, Michael S and Hunstad, David A},
title = {LDL receptor–mediated endocytosis of Escherichia coli α-hemolysin mediates renal epithelial toxicity},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2505482122}
}
EUVIMED